title: Influence of neuropeptides on neutrophil adhesion and transmigration through a lung fibroblast barrier in vitro.
abstract: The lung is richly supplied with peptidergic nerves that store and secrete substance P (SP), vasoactive intestinal peptide (VIP), and other neuropeptides known to potently modulate leukocyte function in vitro and airway inflammation in vivo. We examined the effect of SP, VIP and the novel sensory neuropeptide secretoneurin (SN), as well as of interleukin (IL)-8, IL-6, IL-1 beta, transforming growth factor (TGF)-beta, and tumor necrosis factor (TNF), all associated with acute lung injury, on human neutrophil migration across a 5-mu pore polycarbonate filter system covered by human lung fibroblast monolayers. Additionally, we tested the ability of these neuropeptides to elicit neutrophil adhesion to fibroblast monolayers. SP, but not VIP and SN, may be important in directly influencing neutrophil adhesion to and subsequent migration across a subendothelial barrier of fibroblasts and extracellular matrix towards lung inflammatory sites. The effect was mainly mediated by neurokinin (NK)-1 receptors, as evaluated by a specific NK-1 antagonist, [[(S,S)Pro-Leu(spiro-y-lactam)]9,10, Trp11]substance P (1-11), whereas a specific NK-2 receptor antagonist, [Tyr5, D-Trp6,8,9, Lys10]neurokinin A (4-10), was ineffective. The SP analog septide and the NK-1 receptor agonist ([Sar9 Met(O2)11)SP were comparably effective. Furthermore, the SP effect was concentration and time dependent. However, the other tested neuropeptides might also affect neutrophil recruitment in inflammatory lung by modulating other lung cell functions. Additionally, all tested cytokines stimulated neutrophil transfibroblast migration in vitro, except IL-6. In conclusion, SP in concert with proinflammatory cytokines may regulate neutrophil interstitial accumulation and their traffic to the alveolar space in lung inflammation.
authors.affiliation: Department of Internal Medicine, Division of General Internal Medicine-Pulmonology and ICU, Faculty of Medicine, University of Innsbruck, Innsbruck, Austria. C.M.Kaehler@uibk.ac.at
authors.forename: C M
authors.initials: CM
authors.lastname: Kähler
authors.forename: A
authors.initials: A
authors.lastname: Pischel
authors.forename: G
authors.initials: G
authors.lastname: Kaufmann
authors.forename: C J
authors.initials: CJ
authors.lastname: Wiedermann
mesh_terms: D002448:Cell Adhesion / Q000187:drug effects; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects; D016207:Cytokines / Q000494:pharmacology; D005347:Fibroblasts / Q000502:physiology*; D006801:Humans; D008168:Lung / Q000166:cytology / Q000502:physiology*; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009479:Neuropeptides / Q000494:pharmacology*; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D053381:Secretogranin II; D013373:Substance P / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
chemical_list: D016207:Cytokines; D009479:Neuropeptides; D053381:Secretogranin II; C081159:secretoneurin; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D009240:N-Formylmethionine Leucyl-Phenylalanine